Guang-Yuan Ma (Guangyuan Ma)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Vascular Smooth Muscle Cells

Top Venues

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ruizhi Qiao, Xin Fan, Lei Zhou, Dianchao Dong, Yang Liu, Detai Liu, Guang-Yuan Ma, Na Tang, Yubo Wang, Xiao-Qiang Li, Li Ren, Wei Cao
The synthesis and effects of a novel TRPC6 inhibitor, BP3112, on hepatocellular carcinoma. Future medicinal chemistry (2023)
Ruizhi Qiao, Xin Fan, Lei Zhou, Dianchao Dong, Yang Liu, Detai Liu, Guang-Yuan Ma, Na Tang, Yubo Wang, Xiao-Qiang Li, Li Ren, Wei Cao
The synthesis and effects of a novel TRPC6 inhibitor, BP3112, on hepatocellular carcinoma. Future medicinal chemistry 15 (7) (2023)
Ruizhi Qiao, Xin Fan, Lei Zhou, Dianchao Dong, Yang Liu, Detai Liu, Guang-Yuan Ma, Na Tang, Yubo Wang, Xiao-Qiang Li, Li Ren, Wei Cao
The synthesis and effects of a novel TRPC6 inhibitor, BP3112, on hepatocellular carcinoma. Future medicinal chemistry 15 (7) (2023)
Ruizhi Qiao, Xin Fan, Lei Zhou, Dianchao Dong, Yang Liu, Detai Liu, Guang-Yuan Ma, Na Tang, Yubo Wang, Xiao-Qiang Li, Li Ren, Wei Cao
The synthesis and effects of a novel TRPC6 inhibitor, BP3112, on hepatocellular carcinoma. Future medicinal chemistry 15 (7) (2023)
Yang Sun, Chen Ye, Wen Tian, Wen Ye, Yuan-Yuan Gao, Ying-Da Feng, Hui-Nan Zhang, Guang-Yuan Ma, Shou-Jia Wang, Wei Cao, Xiao-Qiang Li
TRPC1 promotes the genesis and progression of colorectal cancer via activating CaM-mediated PI3K/AKT signaling axis. Oncogenesis 10 (10) (2021)